TNF-α stimulates caspase-3 activation and apoptotic cell death in primary septo-hippocampal cultures

Journal of Neuroscience Research

Volumn 64, Issue 2, 2001, Pages 121-131

  Zhao, Xiurong ^a   Bausano, Brian ^a   Pike, Brian R ^b   Newcomb Fernandez, Jennifer K ^a   Wang, Kevin K W ^c   Shohami, Esther ^d   Ringger, N C ^b   Deford, S M ^b   Anderson, Douglas K ^e   Hayes, Ronald L ^b,f  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Department of Neuroscience ^*  (United States)

^c PFIZER INC   (United States)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

Author keywords

Apoptosis; Calpain; Caspase; Cytokine; Neural injury; Proteolysis

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; AGAROSE; CALPAIN; CASPASE 3; CASPASE INHIBITOR; DNA FRAGMENT; FLUORESCEIN DIACETATE; FODRIN; LACTATE DEHYDROGENASE; PROPIDIUM IODIDE; PROTEIN SYNTHESIS INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL DEATH; CELL STRUCTURE; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; ENZYME ASSAY; GEL ELECTROPHORESIS; HISTOCHEMISTRY; IMMUNOBLOTTING; LACTATE DEHYDROGENASE BLOOD LEVEL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

ANIMALS; APOPTOSIS; ASPARTIC ACID; CALPAIN; CASPASE 3; CASPASES; CELLS, CULTURED; CYCLOHEXIMIDE; CYSTEINE PROTEINASE INHIBITORS; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HIPPOCAMPUS; NERVE TISSUE PROTEINS; NEURONS; PROTEIN SYNTHESIS INHIBITORS; RATS; SEPTUM PELLUCIDUM; SPECTRIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035871964     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.1059     Document Type: Article

References (76)

1. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: Changes in TNF-alpha receptor expression and activation of caspases
2. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors
3. Death receptors: Signaling and modulation
4. 2+ accumulation
5. Tumor necrosis factor-alpha: A mediator of focal ischemic brain injury
6. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF-α receptors
7. Expression of tumor necrosis factor alpha after focal cerebral ischemia in the rat
8. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis
9. Tumor necrosis factor alpha production by astrocytes. Induction by lipopolysaccharide, interferon gamma and interleukin-1-beta
10. Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat
11. Release of TNF-alpha in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage
12. The role of CED-3-related cysteine proteases in apoptosis of cerebellar granule
13. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family
14. Experimental brain injury induces differential expression of tumor necrosis factor-α mRNA in the CNS
15. Elevated circulating tumor necrosis factor levels in Alzheimer's disease
16. A license to kill
17. Neuroprotective action of cyclohexamide involves induction of Bcl-2 and anti-oxidant pathways
18. Neurotoxic components in normal serum
19. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor
20. Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: Implications for AIDS neuropathogenesis
21. Inhibition of caspases prevents cell death of hippocampal CA1 neurons, but not impairment of hippocampal long-term potentiation following ischemia
22. Signal transduction by tumor necrosis factor
23. Cellular localization of tumor necrosis factor-alpha following focal cerebral ischemia in mice
24. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry
25. TNF receptors TR60 and TR80 can mediate apoptsis via induction of distinct signal pathways
26. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide
27. Calpain inhibitors protect against depolarization induced neurofilament protein loss of septo-hippocampal neurons in culture
28. Mechanisms of calpain proteolysis following traumatic brain injury: Implications for pathology and therapy: A review and update
29. Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment
30. Staurosporine-induced neuronal apoptosis
31. Intracerebral injection of caspase-3 inhibitor prevents neuronal apoptosis after kainic acid-evoked status epilepticus
32. Revisting the role of tumor necrosis factor alpha and the response to surgical injury and inflammation
33. Dexanabinol: A novel neuroprotective drug in experimental focal cerebral ischemia
34. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or neurotropic virus
35. Tumor necrosis factor alpha expression in ischemic neurons
36. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation
37. 2+ and neurotoxicity, and increase antioxidant enzyme activities in hippocampal neurons
38. Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia
39. Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation
40. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3
41. Tumor necrosis factor-alpha increases both in the brain and in the cerebrospinal fluid from parkinsonian patients
42. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in ventricular cerebrospinal fluid in juvenile parkinsonian and Parkinson's disease
43. Cytokines and neuropathology
44. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis
45. Effects of ICE-like proteases and calpain inhibitors on neuronal apoptosis
46. Evidence for activation of caspase-3-1ike protease in excitotoxins and hypoxia/ hypoglycemia-injured cerebrocortical neurons
47. Inhibition of tumor necrosis factor ameliorated brain infarction in mice
48. Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease
49. Temporal relationships between de novo protein synthesis, calpain and caspase 3-like protease activation, and DNA fragmentation during apoptosis in septo-hippocampal cultures
50. Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor
51. Rabbit tumor necrosis factor: Mechanisms of action
52. Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain
53. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury
54. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
55. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barre syndrome
56. Closed head injury, triggers early production of TNF-alpha and IL-6 by brain tissue
57. Inhibition of tumor necrosis factor alpha (TNF-α) activity in rat brain is associated with cerebroprotection after closed head injury
58. Cytokine production in the brain following closed head injury: Dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant
59. Dual role of tumor necrosis factor alpha in brain injury
60. Experimental closed head injury: Analysis of neurological outcome, blood brain barrier dysfunction and intracranial polymorphnuclear leukocyte in mice deficient in genes for pro-inflammatory cytokines
61. Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury
62. Increase in IL-6, IL-1 and TNF-α levels in rat brain following traumatic lesion: Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p-site) benzodiazepine ligand
63. Induction of tumor necrosis factor-alpha in the mouse hippocampus following transient forebrain ischemia
64. Caspases and caspase inhibitors
65. Calpain and caspase: Can you tell the difference?
66. Calpain inhibition: An overview of its therapeutic potential
67. Maitotoxin induces calpain activation in SH-SY5Y neuroblastoma cells and cerebrocortical cultures
68. Simultaneous degradation of alpha II- and beta-II- spectrin by caspase 3 (CPP32) in apoptotic cells
69. Concomitant cortical expression of TNF-α and IL-1 mRNAs follows early response gene expression in transient focal ischemia
70. Protective effect of a caspase inhibitor in models for cerebral ischemia in vitro and in vivo
71. Cell death: The significance of apoptosis
72. On the role of galanin in mediating spinal flexor reflex excitability in inflammation
73. Caspases mediate tumor necrosis-alpha-induced neutrophil apoptosis and down-regulation of reactive oxygen production
74. Non-erythroid α-spectrin breakdown by calpain and interleukin 1-converting-enzyme-like protease(s) in apoptotic cells: Contributory roles of both protease families in neuronal apoptosis
75. Maitotoxin induces calpain but not caspase-3 activation and necrotic cell death in primary septo-hippocampal cultures
76. Involvement of cellular proteolytic machinery in apoptosis